Specialty Pharma Journal Specialty, Precision & Technology
No job listings found.
Breaking News
- Bayer Acquires Full Rights to Loxo Oncology’s Vitrakvi and LOXO-195
- FDA Grants Priority Review to Merck’s sBLA for Keytruda Plus Inlyta as First-Line Treatment for Advanced Renal Cell Carcinoma
- FDA Announces Breakthrough Therapy Designation to CymaBay’s Seladelpar for Treatment of Primary Biliary Cholangitis
- Bayer’s Investigational Darolutamide Plus ADT Significantly Extends Metastasis-Free Survival in Phase 3 Study of Non-Metastatic Castration-Resistant Prostate Cancer
- Opdivo Plus Yervoy Shows Response in Pre-Treated Patients with Metastatic Castration-Resistant Prostate Cancer
- Novartis Enters 10-Target Antibody Discovery Deal with AbCellera
- Sarepta Announces FDA Acceptance of Golodirsen NDA for Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 53
- Janssen Announces Preliminary Results from Phase 2 Study in Adults with Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Pathway Defects
- Ultragenyx and Kyowa Kirin Announce Positive Results for Crysvita from Phase 3 Study in Children with X-linked Hypophosphatemia
- Merck Increases Focus on Advanced Prostate Cancer, Expanding Immuno-Oncology Program with Three New Phase 3 Trials